# ABIRATERONE ACETATE
> **ANDA209227** · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK SPECLT · Approved 2019-10-16
## Drug
- **FDA Application Number:** ANDA209227
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ABIRATERONE ACETATE
- **Generic name:** ABIRATERONE ACETATE
- **Active ingredients:** ABIRATERONE ACETATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** GLENMARK SPECLT
- **Manufacturer:** NORTHSTAR RX LLC
- **First approval:** 2019-10-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209227)
---
*MORVS · CC0 1.0*